Evaluation of the PK of NRL972 Following Pre- and co-Administration of Ursodeoxycholic Acid and Cloxacillin

NCT00857480 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Cirrhosis

Interventions

DRUG: NRL972
DRUG: NRL972
DRUG: NRL972

Sponsor

Norgine